The stock price of Cohen & Steers Inc (NYSE: CNS) has jumped by 0.50 compared to previous close of 73.89. Despite this, the company has seen a gain of 0.69% in its stock price over the last five trading days. seekingalpha.com reported 2025-04-17 that Cohen & Steers, Inc. (NYSE:CNS ) Q1 2025 Results Conference Call April 17, 2025 10:00 AM ET Company Participants Brian Heller – Senior Vice President & Deputy Corporate Counsel Raja Dakkuri – Chief Financial Officer John Cheigh – President & Chief Investment Officer Joe Harvey – Chief Executive Officer Conference Call Participants John Dunn – Evercore ISI Operator Ladies and gentlemen, thank you for standing by. Welcome to the Cohen & Steers First Quarter 2025 Earnings Conference Call.
Is It Worth Investing in Cohen & Steers Inc (NYSE: CNS) Right Now?
Cohen & Steers Inc (NYSE: CNS) has a higher price-to-earnings ratio of 24.32x compared to its average ratio. CNS has 36-month beta value of 1.36. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for CNS is 27.38M, and currently, short sellers hold a 6.52% ratio of that float. The average trading volume of CNS on April 18, 2025 was 230.93K shares.
CNS’s Market Performance
The stock of Cohen & Steers Inc (CNS) has seen a 0.69% increase in the past week, with a -6.51% drop in the past month, and a -15.68% fall in the past quarter. The volatility ratio for the week is 3.44%, and the volatility levels for the past 30 days are at 4.06% for CNS. The simple moving average for the last 20 days is -3.56% for CNS’s stock, with a simple moving average of -16.57% for the last 200 days.
Analysts’ Opinion of CNS
Many brokerage firms have already submitted their reports for CNS stocks, with UBS repeating the rating for CNS by listing it as a “Neutral.” The predicted price for CNS in the upcoming period, according to UBS is $102 based on the research report published on October 17, 2024 of the previous year 2024.
UBS, on the other hand, stated in their research note that they expect to see CNS reach a price target of $68. The rating they have provided for CNS stocks is “Sell” according to the report published on January 05th, 2024.
Sidoti gave a rating of “Buy” to CNS, setting the target price at $83 in the report published on February 18th of the previous year.
CNS Trading at -8.59% from the 50-Day Moving Average
After a stumble in the market that brought CNS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.90% of loss for the given period.
Volatility was left at 4.06%, however, over the last 30 days, the volatility rate increased by 3.44%, as shares sank -5.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.94% lower at present.
During the last 5 trading sessions, CNS rose by +0.69%, which changed the moving average for the period of 200-days by +4.77% in comparison to the 20-day moving average, which settled at $77.00. In addition, Cohen & Steers Inc saw -19.58% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CNS starting from Charles Daniel P, who sale 6,868 shares at the price of $103.74 back on Dec 02 ’24. After this action, Charles Daniel P now owns 46,040 shares of Cohen & Steers Inc, valued at $712,463 using the latest closing price.
Charles Daniel P, the Officer of Cohen & Steers Inc, proposed sale 6,868 shares at $103.74 during a trade that took place back on Dec 02 ’24, which means that Charles Daniel P is holding shares at $712,493 based on the most recent closing price.
Stock Fundamentals for CNS
Current profitability levels for the company are sitting at:
- 0.33 for the present operating margin
- 0.66 for the gross margin
The net margin for Cohen & Steers Inc stands at 0.29. The total capital return value is set at 0.22. Equity return is now at value 35.42, with 19.10 for asset returns.
Based on Cohen & Steers Inc (CNS), the company’s capital structure generated 0.22 points at debt to capital in total, while cash flow to debt ratio is standing at 0.82.
Currently, EBITDA for the company is 203.39 million with net debt to EBITDA at -0.21. When we switch over and look at the enterprise to sales, we see a ratio of 7.12. The receivables turnover for the company is 6.93for trailing twelve months and the total asset turnover is 0.65.
Conclusion
To put it simply, Cohen & Steers Inc (CNS) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
